{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:06:34Z","timestamp":1785308794042,"version":"3.55.0"},"reference-count":45,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.o46","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:29:20Z","timestamp":1785234560000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Levey AS. Defining AKD: the spectrum of AKI, AKD, and CKD. Nephron. 2022;146(3):302-305. doi:10.1159\/000516647","DOI":"10.1159\/000516647"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Hannan M, Ansari S, Meza N, et al. Risk factors for CKD progression: overview of findings from the CRIC Study. Clin J Am Soc Nephrol. 2021;16(4):648-659. doi:10.2215\/CJN.07830520","DOI":"10.2215\/CJN.07830520"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Wei S, Liu N, Fu Y, Sun M. Novel insights into modifiable risk factors for arteriovenous fistula failure and the importance of CKD lipid profile: a meta-analysis. J Vasc Access. 2024;25(5):1416-1431. doi:10.1177\/11297298221115557","DOI":"10.1177\/11297298221115557"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Banerjee D, Rosano G, Herzog CA. Management of heart failure patient with CKD. Clin J Am Soc Nephrol. 2021;16(7):1131-1139. doi:10.2215\/CJN.14180920","DOI":"10.2215\/CJN.14180920"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Adamska-Welnicka A, Welnicki M, Mamcarz A, Gellert R. Chronic kidney disease and heart failure-everyday diagnostic challenges. Diagnostics (Basel). 2021;11(11)doi:10.3390\/diagnostics11112164","DOI":"10.3390\/diagnostics11112164"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Kipourou K, O'Driscoll JM, Sharma R. Valvular heart disease in patients with chronic kidney disease. Eur Cardiol. 2022;17:e02. doi:10.15420\/ecr.2021.25","DOI":"10.15420\/ecr.2021.25"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Stoumpos S, Van Rhijn P, Mangion K, Thomson PC, Mark PB. Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients. Clin Kidney J. 2024;17(5):sfae105. doi:10.1093\/ckj\/sfae105","DOI":"10.1093\/ckj\/sfae105"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Patel RB, Fonarow GC, Greene SJ, et al. Kidney function and outcomes in patients hospitalized with heart failure. J Am Coll Cardiol. 2021;78(4):330-343. doi:10.1016\/j.jacc.2021.05.002","DOI":"10.1016\/j.jacc.2021.05.002"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696-707. doi:10.1038\/s41581-022-00616-6","DOI":"10.1038\/s41581-022-00616-6"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157-1172. doi:10.1161\/CIRCULATIONAHA.120.050686","DOI":"10.1161\/CIRCULATIONAHA.120.050686"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Hirabayashi K, Fujii H, Kono K, et al. Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease. Clin Exp Nephrol. 2024;28(4):307-315. doi:10.1007\/s10157-023-02437-8","DOI":"10.1007\/s10157-023-02437-8"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. doi:10.1056\/NEJMoa041031","DOI":"10.1056\/NEJMoa041031"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001;38(1):13-18. doi:10.1161\/01.hyp.38.1.13","DOI":"10.1161\/01.HYP.38.1.13"},{"issue":"7","key":"ref13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","unstructured":"14. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11(7):1277-1285.","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186-192. doi:10.1038\/ki.1995.22","DOI":"10.1038\/ki.1995.22"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. London G. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant. 2001;16(Suppl 2):3-6. doi:10.1093\/ndt\/16.suppl_2.3","DOI":"10.1093\/ndt\/16.suppl_2.3"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Huting J, Kramer W, Schutterle G, Wizemann V. Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron. 1988;49(4):284-290. doi:10.1159\/000185077","DOI":"10.1159\/000185077"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Huting J, Alpert MA. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin Cardiol. 1992;15(3):190-196.","DOI":"10.1002\/clc.4960151012"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66(6):2389-2401. doi:10.1111\/j.1523-1755.2004.66028.x","DOI":"10.1111\/j.1523-1755.2004.66028.x"},{"issue":"2","key":"ref19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/089686080602600220","article-title":"Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant","volume":"26","author":"Frimat","year":"2006","unstructured":"20. Frimat L, Durand PY, Loos-Ayav C, et al. Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int. 2006;26(2):231-239.","journal-title":"Perit Dial Int"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Peteiro J, Alvarez N, Calvino R, Penas M, Ribera F, Castro Beiras A. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Cardiology. 1994;85(5):273-283. doi:10.1159\/000176695","DOI":"10.1159\/000176695"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Ferreira SR, Moises VA, Tavares A, Pacheco-Silva A. Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation. 2002;74(11):1580-1587. doi:10.1097\/00007890-200212150-00016","DOI":"10.1097\/00007890-200212150-00016"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Huting J. Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol. 1992;70(18):1481-1484. doi:10.1016\/0002-9149(92)90303-g","DOI":"10.1016\/0002-9149(92)90303-G"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med. 1988;84(6):985-992. doi:10.1016\/0002-9343(88)90302-6","DOI":"10.1016\/0002-9343(88)90302-6"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Munclinger M, Nemecek K, Serf B, Vondracek V, Hrudova J. Effect of arteriovenous fistula creation and maturation on rest hemodynamics in patients with end-stage renal disease. Nephron. 1987;46(1):105-106. doi:10.1159\/000184321","DOI":"10.1159\/000184321"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Crowley ST, Morrissey RL, Silverman ED, Yudt WM, Hirszel P. Renal hemodynamic response to the creation of vascular access in patients with end-stage renal disease. Ren Fail. 1995;17(5):589-593. doi:10.3109\/08860229509037623","DOI":"10.3109\/08860229509037623"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Ori Y, Korzets A, Katz M, et al. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy. Am J Kidney Dis. 2002;40(4):745-752. doi:10.1053\/ajkd.2002.35685","DOI":"10.1053\/ajkd.2002.35685"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. van Duijnhoven EC, Cheriex EC, Tordoir JH, Kooman JP, van Hooff JP. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant. 2001;16(2):368-372. doi:10.1093\/ndt\/16.2.368","DOI":"10.1093\/ndt\/16.2.368"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Unger P, Wissing KM, de Pauw L, Neubauer J, van de Borne P. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation. 2002;74(1):73-79. doi:10.1097\/00007890-200207150-00013","DOI":"10.1097\/00007890-200207150-00013"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ, Ianhez LE, Krieger EM. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology. 1999;92(4):236-239. doi:10.1159\/000006980","DOI":"10.1159\/000006980"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Melvinsdottir I, Foley DP, Hess T, et al. Heart and kidney transplant: should they be combined or subsequent? ESC Heart Fail. 2020;7(5):2734-2743. doi:10.1002\/ehf2.12864","DOI":"10.1002\/ehf2.12864"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Gallo M, Trivedi JR, Schumer EM, Slaughter MS. Combined heart-kidney transplant versus sequential kidney transplant in heart transplant recipients. J Card Fail. 2020;26(7):574-579. doi:10.1016\/j.cardfail.2020.03.002","DOI":"10.1016\/j.cardfail.2020.03.002"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Kobashigawa J, Dadhania DM, Farr M, et al. Consensus conference on heart-kidney transplantation. Am J Transplant. 2021;21(7):2459-2467. doi:10.1111\/ajt.16512","DOI":"10.1111\/ajt.16512"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Israni AK, Snyder JJ, Skeans MA, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010;10(2):338-353. doi:10.1111\/j.1600-6143.2009.02949.x","DOI":"10.1111\/j.1600-6143.2009.02949.x"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Cheng XS, Liu S, Han J, et al. Association of pretransplant coronary heart disease testing with early kidney transplant outcomes. JAMA Intern Med. 2023;183(2):134-141. doi:10.1001\/jamainternmed.2022.6069","DOI":"10.1001\/jamainternmed.2022.6069"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Cassuto JR, Reese PP, Bloom RD, et al. Kidney transplantation in patients with a prior heart transplant. Transplantation. 2010;89(4):427-433. doi:10.1097\/TP.0b013e3181c42248","DOI":"10.1097\/TP.0b013e3181c42248"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Schulman DS, Herman BA, Edwards TD, Ziady G, Uretsky BF. Diastolic dysfunction in cardiac transplant recipients: an important role in the response to increased afterload. Am Heart J. 1993;125(2 Pt 1):435-442. doi:10.1016\/0002-8703(93)90023-3","DOI":"10.1016\/0002-8703(93)90023-3"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Hamidi S, Kojuri J, Attar A, Roozbeh J, Moaref A, Nikoo MH. The effect of kidney transplantation on speckled tracking echocardiography findings in patients on hemodialysis. J Cardiovasc Thorac Res. 2018;10(2):90-94. doi:10.15171\/jcvtr.2018.14","DOI":"10.15171\/jcvtr.2018.14"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Souza FL, Bezerra KB, Sousa AR, et al. Study of echocardiographic alterations in the first six months after kidney transplantation. Arq Bras Cardiol. 2012;98(6):505-513. doi:10.1590\/s0066-782x2012005000040","DOI":"10.1590\/S0066-782X2012005000040"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Sharma R, Chemla E, Tome M, et al. Echocardiography-based score to predict outcome after renal transplantation. Heart. 2007;93(4):464-469. doi:10.1136\/hrt.2006.096826","DOI":"10.1136\/hrt.2006.096826"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Papasotiriou M, Xanthopoulou I, Ntrinias T, et al. Impact of arteriovenous fistula on cardiac size and function in kidney transplant recipients: a retrospective evaluation of 5-year echocardiographic outcome. Exp Clin Transplant. 2019;17(5):619-626. doi:10.6002\/ect.2018.0331","DOI":"10.6002\/ect.2018.0331"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Cridlig J, Selton-Suty C, Alla F, et al. Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int. 2008;21(10):948-954. doi:10.1111\/j.1432-2277.2008.00707.x","DOI":"10.1111\/j.1432-2277.2008.00707.x"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Stoumpos S, Rankin A, Hall Barrientos P, et al. Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Sci Rep. 2021;11(1):18102. doi:10.1038\/s41598-021-97625-5","DOI":"10.1038\/s41598-021-97625-5"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA. Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease. Eur Heart J. 2017;38(24):1913-1923. doi:10.1093\/eurheartj\/ehx045","DOI":"10.1093\/eurheartj\/ehx045"},{"key":"ref44","unstructured":"45. Soleimani MJ, Shahrokh H, Shadpour P, Shirani M, Arasteh S. Impact of dialysis access fistula on cardiac function after kidney transplantation. Iran J Kidney Dis. 2012;6(3):198-202."}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:41:06Z","timestamp":1785307266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/115\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.o46","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}